News About: R&D
Establishment of Korea Pharmaceuticals Development Forum eyed
With the outlook that Korean-block-buster new drugs are likely to be launched within 10 years, a R&D new drug forum has been recently established for its earnest operation.
The Korea Drug Research Association (KDRA...
Patent applications for osteoporosis drugs on the rise yearly by 25%.
Apart from ever rising trend in so called "Quality of Life" enhancing drugs, number of patent applications for the osteoporosis drug development also shows a remarkable growing stance yearly by 25%.
The Patent Offi...
Xalatan to delay glaucoma in patients with increased intraocular pressure
The reduction in intraocular pressure (IOP) is associated with far less risk of inducing glaucoma, which may cause blindness and loss of vision, according to a 5-year AccorOcular Hypertension Treatment Study (OHTS) of...
A US-Korea workshop on lifescience sector to be held on the coming 19～21 this month
The Korean Association of Institutional Review Boards (KAIRB) announced that an international workshop entitled "Legal and ethical aspects of subjects in the clinical trials" will be held in a clinical research instit...
Clinical trials underway for 15 new drugs
The Korea Food and Drug Administration announced that clinical trials are underway for 15 new drugs by domestic and foreign-invested pharmaceutical firms in Korea. Details:
Product (ingredient)
Compa...
24 new drugs commercialized successfully since 1987
The Korea Drug Research Association (KDRA) says that a total of 24 R& D drug projects were successfully streamlined for the commercialization and technology transfer according to its report on the outcomes of R&D proj...
Pharmaceutical technology trade on the rush.
The technology business transaction appeared with a brisk trend these days in the pharmaceutical area such as liver cancer drugs and in the bio-engineering fields as gene scanning know-how.
The Korea Health Industr...
Eight bioventure centers to lead the domestic bioindustry
Market observers say that a total of eight bioventure centers (BVCs) across the country, which is being promoted by the Ministry of Commerce, Industry and Energy (MOCIE), has heralded the opening of a new era ...
Domestic pharmaceutical firms' strategic alliances with bioventure firms up
In his recent report, a researcher Kim Seok-kwan, Industry Renovation Research Unit of Science & Technology Policy Institute, says that under the circumstances where R&D outlays of the domestic pharmaceutical firms ha...
LG and Ilsung Pharm to execute the technical transfer agreement
LG Household and Health Care and Ilsung Pharm have recently executed the technical transfer agreement on 'Ulmi Cortex', an antiperiodental agent.
There is a growing concern that the technology of a household maker ...
